Sunitha Kakarla

1.3k total citations
13 papers, 1.1k citations indexed

About

Sunitha Kakarla is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sunitha Kakarla has authored 13 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Immunology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sunitha Kakarla's work include CAR-T cell therapy research (11 papers), Immunotherapy and Immune Responses (5 papers) and Peptidase Inhibition and Analysis (4 papers). Sunitha Kakarla is often cited by papers focused on CAR-T cell therapy research (11 papers), Immunotherapy and Immune Responses (5 papers) and Peptidase Inhibition and Analysis (4 papers). Sunitha Kakarla collaborates with scholars based in United States, Germany and Netherlands. Sunitha Kakarla's co-authors include Stephen Gottschalk, Xiao‐Tong Song, Kevin Chow, Hao Liu, Donald R. Shaffer, David R. Rowley, Klaus Pfizenmaier, Melinda Mata, Meng-Fen Wu and Zhongzhen Yi and has published in prestigious journals such as Blood, PLoS ONE and Scientific Reports.

In The Last Decade

Sunitha Kakarla

13 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sunitha Kakarla United States 9 936 403 296 274 229 13 1.1k
Elizabeth L. Siegler United States 14 910 1.0× 398 1.0× 444 1.5× 346 1.3× 198 0.9× 37 1.2k
Alexander J. Davenport Australia 12 859 0.9× 478 1.2× 296 1.0× 273 1.0× 205 0.9× 24 1.1k
Kevin Chow United States 11 982 1.0× 416 1.0× 382 1.3× 270 1.0× 263 1.1× 16 1.2k
Vita S. Brawley United States 10 1.0k 1.1× 429 1.1× 442 1.5× 313 1.1× 326 1.4× 14 1.2k
Chuang Sun United States 15 870 0.9× 390 1.0× 329 1.1× 389 1.4× 232 1.0× 18 1.1k
Sherly Mardiana Australia 12 1.2k 1.3× 824 2.0× 306 1.0× 444 1.6× 256 1.1× 13 1.5k
Hillary G. Caruso United States 8 539 0.6× 297 0.7× 234 0.8× 276 1.0× 121 0.5× 14 813
Skyler P. Rietberg United States 7 779 0.8× 309 0.8× 297 1.0× 324 1.2× 184 0.8× 9 1.0k
Liang-Chuan Wang United States 7 677 0.7× 372 0.9× 228 0.8× 226 0.8× 163 0.7× 14 867
Mythili Koneru United States 13 1.3k 1.4× 769 1.9× 381 1.3× 440 1.6× 344 1.5× 29 1.7k

Countries citing papers authored by Sunitha Kakarla

Since Specialization
Citations

This map shows the geographic impact of Sunitha Kakarla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sunitha Kakarla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sunitha Kakarla more than expected).

Fields of papers citing papers by Sunitha Kakarla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sunitha Kakarla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sunitha Kakarla. The network helps show where Sunitha Kakarla may publish in the future.

Co-authorship network of co-authors of Sunitha Kakarla

This figure shows the co-authorship network connecting the top 25 collaborators of Sunitha Kakarla. A scholar is included among the top collaborators of Sunitha Kakarla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sunitha Kakarla. Sunitha Kakarla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Velasquez, Mireya Paulina, David Torres, Kota Iwahori, et al.. (2016). T cells expressing CD19-specific Engager Molecules for the Immunotherapy of CD19-positive Malignancies. Scientific Reports. 6(1). 27130–27130. 45 indexed citations
2.
Tzannou, Ifigeneia, Kathryn Leung, Caridad Martinez, et al.. (2016). Safety and Preliminary Efficacy of "Ready to Administer" Cytomegalovirus (CMV)-Specific T Cells for the Treatment of Patients with Refractory CMV Infection. Blood. 128(22). 388–388. 1 indexed citations
3.
Velasquez, Mireya Paulina, et al.. (2015). Costimulation to enhance the antitumor activity of CD19 eng T cells. Journal for ImmunoTherapy of Cancer. 3(S2). 1 indexed citations
4.
Morgan, Richard A. & Sunitha Kakarla. (2014). Genetic Modification of T Cells. The Cancer Journal. 20(2). 145–150. 11 indexed citations
5.
Kakarla, Sunitha & Stephen Gottschalk. (2014). CAR T Cells for Solid Tumors. The Cancer Journal. 20(2). 151–155. 157 indexed citations
6.
Iwahori, Kota, Sunitha Kakarla, Mireya Paulina Velasquez, et al.. (2014). Engager T Cells: A New Class of Antigen-specific T Cells That Redirect Bystander T Cells. Molecular Therapy. 23(1). 171–178. 81 indexed citations
7.
Gottschalk, Stephen, Yu Feng, Minjun Ji, Sunitha Kakarla, & Xiao‐Tong Song. (2013). A Vaccine That Co-Targets Tumor Cells and Cancer Associated Fibroblasts Results in Enhanced Antitumor Activity by Inducing Antigen Spreading. PLoS ONE. 8(12). e82658–e82658. 50 indexed citations
8.
Kakarla, Sunitha, Kevin Chow, Melinda Mata, et al.. (2013). Antitumor Effects of Chimeric Receptor Engineered Human T Cells Directed to Tumor Stroma. Molecular Therapy. 21(8). 1611–1620. 277 indexed citations
9.
Kakarla, Sunitha, Kevin Chow, Melinda Mata, et al.. (2013). Anti-Tumor Effects of Chimeric Receptor Engineered Human T Cells Directed to Tumor Stroma. Biology of Blood and Marrow Transplantation. 19(2). S348–S349. 7 indexed citations
10.
Chow, Kevin, Swati Naik, Sunitha Kakarla, et al.. (2012). T Cells Redirected to EphA2 for the Immunotherapy of Glioblastoma. Molecular Therapy. 21(3). 629–637. 196 indexed citations
11.
Kakarla, Sunitha, Xiao‐Tong Song, & Stephen Gottschalk. (2012). Cancer-Associated Fibroblasts as Targets for Immunotherapy. Immunotherapy. 4(11). 1129–1138. 91 indexed citations
12.
Shaffer, Donald R., Barbara Savoldo, Zhongzhen Yi, et al.. (2011). T cells redirected against CD70 for the immunotherapy of CD70-positive malignancies. Blood. 117(16). 4304–4314. 131 indexed citations
13.
Kakarla, Sunitha, et al.. (2011). Improving T-Cell Immunotherapies for Solid Tumors by Targeting the Tumor Stroma. Biology of Blood and Marrow Transplantation. 17(2). S270–S270. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026